Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease

  • Tomohiro Nakamura*
  • , Chang Ki Oh
  • , Lujian Liao
  • , Xu Zhang
  • , Kevin M. Lopez
  • , Daniel Gibbs
  • , Amanda K. Deal
  • , Henry R. Scott
  • , Brian Spencer
  • , Eliezer Masliah
  • , Robert A. Rissman
  • , John R. Yates
  • , Stuart A. Lipton*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Abstract

Here we describe mechanistically distinct enzymes (a kinase, a guanosine triphosphatase, and a ubiquitin protein hydrolase) that function in disparate biochemical pathways and can also act in concert to mediate a series of redox reactions. Each enzyme manifests a second, noncanonical function-transnitrosylation-that triggers a pathological biochemical cascade in mouse models and in humans with Alzheimer's disease (AD). The resulting series of transnitrosylation reactions contributes to synapse loss, the major pathological correlate to cognitive decline in AD. We conclude that enzymes with distinct primary reaction mechanisms can form a completely separate network for aberrant transnitrosylation. This network operates in the postreproductive period, so natural selection against such abnormal activity may be decreased.

Original languageEnglish
Article numbereaaw0843
JournalScience
Volume371
Issue number6526
DOIs
StatePublished - 15 Jan 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this